Yi Heng Chen

USPTO Granted Patents = 77 (Patent Applications = 42)

CIPO Patents = 7 (Patent Applications = 10)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 2.9

ph-index = 15

Forward Citations = 634(Granted Patents)

DiyaCoin

= 1.18

Location History:

Essex County, NJ (US) (2003)
San José, CA (US) (2015)
Lexington, MA (US) (2015 - 2016)
St. Charles, MO (US) (2010 - 2020)
Lawrenceville, NJ (US) (2015 - 2020)
Whippany, NJ (US) (2020)
San Mateo, CA (US) (2010 - 2022)
Cambridge, MA (US) (2016 - 2022)
Nutley, NJ (US) (2000 - 2024)
San Jose, CA (US) (2003 - 2024)
Pleasanton, CA (US) (2015 - 2024)

Company Filing History:

16 out of 16

Newave Pharmaceutical Inc.

Massachusetts Institute of Technology

Hoffmann-la Roche Inc.

patents

6. 5 out of 24

Purdue Pharmaceutical Products L.p.

patents

7. 4 out of 967

Midea Group Co., Ltd.

Pmv Pharmaceuticals, Inc.

patents

10. 2 out of 2,405

Merck Sharp + Dohme Corp.

patents

11. 1 out of 1

Purdue Pharmaceuticals Products L.p.

Hudson Biopharma Inc.

patent

14. 1 out of 1

Crystal Biopharmaceutical LLC

patent

15. 1 out of 35

Merck Sharpe & Dohme Corp.

where one patent can have more than one assignee

Years Active: 2000-2025

where 'Filed Patents' based on already Granted Patents

77 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12410190 - Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases (2025-09-09),

2. 12365992 - Electronic devices having corrosion-resistant coatings (2025-07-22),

3. 12220419 - BCL-2 inhibitors (2025-02-11),

4. 12115685 - Fast and robust initialization method for feature-based monocular visual SLAM using inertial odometry assistance (2024-10-15),

5. 12086788 - Substituted pyrazines as inhibitors of BTK, and mutants thereof (2024-09-10),

6. 12037393 - P116 antibodies (2024-07-16),

7. 11993610 - BCL-2 inhibitors (2024-05-28),

8. 11926632 - Methods and compounds for restoring mutant p53 function (2024-03-12),

9. 11903950 - BCL-2 inhibitors (2024-02-20),

10. 11756231 - Method and apparatus for scale calibration and optimization of a monocular visual-inertial localization system (2023-09-12),

11. 11731953 - Methods and compounds for restoring mutant p53 function (2023-08-22),

12. 11724004 - Transglutaminase treated products (2023-08-15),

13. 11680072 - Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases (2023-06-20),

14. 11521332 - Method and apparatus for optimization of a monocular visual-inertial localization system (2022-12-06),

15. 11501284 - Substituted pyrazines as inhibitors of BTK, and mutants thereof (2022-11-15),

Title: The Innovative Journey of Yi Heng Chen

Introduction: Yi Heng Chen, a talented inventor based in Whippany, NJ, has made significant contributions to the field of technology with his creative solutions and groundbreaking ideas.

Latest Patents: Yi Heng Chen's latest patents include a cutting-edge software application for optimizing energy consumption in smart homes and a revolutionary medical device for monitoring vital signs remotely.

Career Highlights: With a background in electrical engineering, Yi Heng Chen has worked for several leading tech companies, where he honed his skills in product development and innovation. His career highlights include being part of the team that developed a state-of-the-art drone delivery system and receiving recognition for his contributions to the development of a virtual reality gaming platform.

Collaborations: Throughout his career, Yi Heng Chen has collaborated with top researchers and engineers in the industry to bring his ideas to life. His collaborative projects have resulted in groundbreaking inventions that have had a significant impact on various sectors, from healthcare to entertainment.

Conclusion: Yi Heng Chen's passion for innovation and his dedication to pushing the boundaries of technology make him a standout figure in the world of inventors. His relentless pursuit of excellence continues to inspire others in the field to think outside the box and create solutions that shape the future.

This text is generated by artificial intelligence and may not be accurate.